Skip to content

CRISPR-Cas9 und mRNA-Technologie

Last Login: 04/23/2026


Blurred line chart showing the performance of a wikifolio as background

Want the full picture?

To view the wikifolio chart since its creation and compare it with benchmarks of your choice, register now – completely free of charge.

-51.1%
since 7/15/2021

-13.8%
Ø-Perf. per year

-1.5%
Performance (1yr)

-
Volatility (1yr)

-0.4
Return/Risk



Portfolio chart

Details
Blurred pie chart showing the distribution of stocks by sectors and countries as background

Want the full picture?

To see which sectors and countries the stocks in this wikifolio are spread across, register now – completely free of charge.

Tags

Feed

Trading Idea

In diesem Wikifolio werden Aktien von Unternehmen gekauft, die rund um das Thema Geneditierung u. a. mithilfe von CRISPR-Cas9, der Genschere aus Enzym und RNA, und der mRNA-Technologie operieren. Die mRNA-Technologie hat bereits bei dem Impfstoff gegen COVID-19 gezeigt, wozu sie in der Lage ist. Geneditierung steckt hingegen noch in den Kinderschuhen. Hier sind aber für die nächsten Jahre erste Erfolge abzusehen. Das Potential ist in beiden Bereichen enorm!

This content is not available in the current language.

Master data

Symbol

WFCRISPRNA

Date created

07/15/2021

Index level

-

High watermark

54.2

Investment Universe

Blurred table showing portfolio positions and key figures as background

Want the full picture?

To view the complete portfolio, all key figures, and previous trades, register now – completely free of charge.

For the composition of the virtual portfolio click here.